Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Semaxanib> ?p ?o }
Showing triples 1 to 87 of
87
with 100 triples per page.
- Semaxanib abstract "Semaxanib (SU5416) is a tyrosine-kinase inhibitor drug designed by SUGEN as a cancer therapeutic. It is an experimental stage drug, not licensed for use on human patients outside of clinical trials.Semaxanib is a potent and selective synthetic inhibitor of the Flk-1/KDR vascular endothelial growth factor (VEGF) receptor tyrosine kinase. It targets the VEGF pathway, and both in vivo and in vitro studies have demonstrated antiangiogenic potential.On February 2002, Pharmacia, the then-parent of Sugen, prematurely ended Phase III clinical trials of semaxinib in the treatment of advanced colorectal cancer due to discouraging results. Other studies, at earlier phases, have since been conducted. However, due to the prospect of next-generation tyrosine kinase inhibitors and the ineffaciousness of semaxanib in clinic trials, further development of the drug has been discontinued. A related compound, SU11248 was further developed by Sugen, and then by Pfizer and was FDA-approved as sunitinib (Sutent) for treatment of renal carcinoma in January 2006.".
- Semaxanib atcPrefix "none".
- Semaxanib casNumber "194413-58-6".
- Semaxanib fdaUniiCode "71IA9S35AJ".
- Semaxanib iupacName "(3Z)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1,3-dihydro-2H-indol-2-one".
- Semaxanib pubchem "5329098".
- Semaxanib thumbnail Semaxanib.svg?width=300.
- Semaxanib wikiPageID "9751443".
- Semaxanib wikiPageLength "5261".
- Semaxanib wikiPageOutDegree "21".
- Semaxanib wikiPageRevisionID "679081706".
- Semaxanib wikiPageWikiLink Angiogenesis_inhibitor.
- Semaxanib wikiPageWikiLink Antiangiogenic.
- Semaxanib wikiPageWikiLink Category:Indolines.
- Semaxanib wikiPageWikiLink Category:Lactams.
- Semaxanib wikiPageWikiLink Category:Pyrroles.
- Semaxanib wikiPageWikiLink Category:Receptor_tyrosine_kinase_inhibitors.
- Semaxanib wikiPageWikiLink Clinical_trial.
- Semaxanib wikiPageWikiLink Colorectal_cancer.
- Semaxanib wikiPageWikiLink In_vitro.
- Semaxanib wikiPageWikiLink In_vivo.
- Semaxanib wikiPageWikiLink Investigational_product.
- Semaxanib wikiPageWikiLink Kinase_inhibitor.
- Semaxanib wikiPageWikiLink Pfizer.
- Semaxanib wikiPageWikiLink Pharmacia.
- Semaxanib wikiPageWikiLink Protein_kinase_inhibitor.
- Semaxanib wikiPageWikiLink Regulation_of_therapeutic_goods.
- Semaxanib wikiPageWikiLink SUGEN.
- Semaxanib wikiPageWikiLink Sunitinib.
- Semaxanib wikiPageWikiLink Tyrosine-kinase_inhibitor.
- Semaxanib wikiPageWikiLink Tyrosine_kinase.
- Semaxanib wikiPageWikiLink VEGF_pathway.
- Semaxanib wikiPageWikiLink Vascular_endothelial_growth_factor.
- Semaxanib wikiPageWikiLinkText "Semaxanib".
- Semaxanib wikiPageWikiLinkText "semaxanib".
- Semaxanib atcPrefix "none".
- Semaxanib c "15".
- Semaxanib casNumber "194413".
- Semaxanib chembl "276711".
- Semaxanib chemspiderid "4486260".
- Semaxanib h "14".
- Semaxanib hasPhotoCollection Semaxanib.
- Semaxanib inchi "1".
- Semaxanib inchikey "WUWDLXZGHZSWQZ-WQLSENKSBZ".
- Semaxanib iupacName "-3".
- Semaxanib iupharLigand "5056".
- Semaxanib molecularWeight "238.285".
- Semaxanib n "2".
- Semaxanib o "1".
- Semaxanib pubchem "5329098".
- Semaxanib smiles "O=C2C=C/c3cC".
- Semaxanib stdinchi "1".
- Semaxanib stdinchikey "WUWDLXZGHZSWQZ-WQLSENKSSA-N".
- Semaxanib unii "71".
- Semaxanib verifiedfields "changed".
- Semaxanib verifiedrevid "464389051".
- Semaxanib wikiPageUsesTemplate Template:Antineoplastic-drug-stub.
- Semaxanib wikiPageUsesTemplate Template:Drugbox.
- Semaxanib wikiPageUsesTemplate Template:Extracellular_chemotherapeutic_agents.
- Semaxanib wikiPageUsesTemplate Template:Reflist.
- Semaxanib subject Category:Indolines.
- Semaxanib subject Category:Lactams.
- Semaxanib subject Category:Pyrroles.
- Semaxanib subject Category:Receptor_tyrosine_kinase_inhibitors.
- Semaxanib hypernym Drug.
- Semaxanib type ChemicalSubstance.
- Semaxanib type Drug.
- Semaxanib type Amide.
- Semaxanib type Azole.
- Semaxanib type Chemical.
- Semaxanib type Drug.
- Semaxanib type Heterocycle.
- Semaxanib type Inhibitor.
- Semaxanib type Lactam.
- Semaxanib type ChemicalObject.
- Semaxanib type Thing.
- Semaxanib type Q8386.
- Semaxanib comment "Semaxanib (SU5416) is a tyrosine-kinase inhibitor drug designed by SUGEN as a cancer therapeutic. It is an experimental stage drug, not licensed for use on human patients outside of clinical trials.Semaxanib is a potent and selective synthetic inhibitor of the Flk-1/KDR vascular endothelial growth factor (VEGF) receptor tyrosine kinase.".
- Semaxanib label "Semaxanib".
- Semaxanib sameAs m.02pr1xh.
- Semaxanib sameAs Semaksanib.
- Semaxanib sameAs Semaksanib.
- Semaxanib sameAs Q7449140.
- Semaxanib sameAs Q7449140.
- Semaxanib wasDerivedFrom Semaxanib?oldid=679081706.
- Semaxanib depiction Semaxanib.svg.
- Semaxanib isPrimaryTopicOf Semaxanib.